Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Applied Therapeutics Inc (NASDAQ: APLT) was $1.15 for the day, up 1.77% from the previous closing price of $1.13. In other words, the price has increased by $1.77 from its previous closing price. On the day, 1.62 million shares were traded. APLT stock price reached its highest trading level at $1.24 during the session, while it also had its lowest trading level at $1.0902.
Ratios:
Our analysis of APLT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.94 and its Current Ratio is at 1.94. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.12.
On December 02, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $13 to $2.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 29, 2024, whereas the target price for the stock was revised from $12 to $4.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’25 when Perfetti Riccardo sold 10,366 shares for $0.44 per share. The transaction valued at 4,561 led to the insider holds 890,409 shares of the business.
Funtleyder Leslie D. sold 14,502 shares of APLT for $6,381 on Mar 04 ’25. The insider now owns 390,459 shares after completing the transaction at $0.44 per share. On Mar 04 ’25, another insider, Chinoporos Constantine, who serves as the insider of the company, sold 447 shares for $0.44 each. As a result, the insider received 197 and left with 271,436 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 165613936 and an Enterprise Value of 137794944. For the stock, the TTM Price-to-Sale (P/S) ratio is 1380.08 while its Price-to-Book (P/B) ratio in mrq is 9.36. Its current Enterprise Value per Revenue stands at 1138.801 whereas that against EBITDA is -1.237.
Stock Price History:
The Beta on a monthly basis for APLT is 2.08, which has changed by -0.8758099 over the last 52 weeks, in comparison to a change of 0.19736934 over the same period for the S&P500. Over the past 52 weeks, APLT has reached a high of $10.62, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is 40.97%, while the 200-Day Moving Average is calculated to be 109.92%.
Shares Statistics:
APLT traded an average of 4.78M shares per day over the past three months and 2658470 shares per day over the past ten days. A total of 141.94M shares are outstanding, with a floating share count of 126.84M. Insiders hold about 11.93% of the company’s shares, while institutions hold 61.14% stake in the company. Shares short for APLT as of 1760486400 were 8982763 with a Short Ratio of 1.88, compared to 1757894400 on 9129207. Therefore, it implies a Short% of Shares Outstanding of 8982763 and a Short% of Float of 6.280000500000001.
Earnings Estimates
Applied Therapeutics Inc (APLT) is presently subject to a detailed evaluation by 3.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.09 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.45 and -$0.66 for the fiscal current year, implying an average EPS of -$0.57. EPS for the following year is -$0.54, with 3.0 analysts recommending between -$0.32 and -$0.66.
